Method for preparing nanogold compound for treating peritoneal cancer based on artemisinin

By combining artemisinin with nanogold, an artemisinin-modified nanogold complex was prepared, which solved the problems of large side effects and low targeting of existing methods for treating peritoneal cancer, and achieved efficient targeted treatment of peritoneal cancer cells and improved bioavailability.

CN120227373APending Publication Date: 2025-07-01SUZHOU NANO HEALTH RES INST CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311847046.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-12-29
Publication Date
2025-07-01

AI Technical Summary

Technical Problem

The existing methods for treating peritoneal cancer have problems such as having great side effects, serious damage to normal tissues, difficulty in early diagnosis and treatment, and the targeting and bioavailability of traditional drugs are relatively low.

Method used

By combining artemisinin with nanogold, an artemisinin-modified nanogold complex was prepared, and the biocompatibility of nanogold and the anti-cancer properties of artemisinin were used to achieve efficient targeted treatment of peritoneal cancer cells.

Benefits of technology

This method improves the targeting and therapeutic effect of peritoneal cancer cells, reduces toxicity and side effects on normal tissues, enhances the bioavailability and delivery efficiency of drugs, and can effectively inhibit the proliferation and angiogenesis of cancer cells.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a method for preparing a nanogold compound for treating peritoneal cancer based on artemisinin, and aims to prepare and modify nanogold particles for treating peritoneal cancer. The compound is composed of nanogold modified by artemisinin. The compound brings a brand new treatment scheme for the field of peritoneal cancer treatment due to excellent biocompatibility and high targeting property. By guiding artemisinin modified nanogold to peritoneal cancer cells, the invention aims to improve the accuracy and effect of treatment, thereby reducing the damage to normal cells in the treatment process.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of nanomaterials, and particularly to a method for preparing a nano-gold complex based on artemisinin for the treatment of peritoneal cancer. Background Art

[0002] Peritoneal cancer is a rare but malignant tumor type with an increasing incidence, and current treatment methods still face challenges. Conventional treatment methods such as surgical resection, radiotherapy, and chemotherapy have certain limitations in improving the survival rate of patients. Especially because peritoneal cancer is often difficult to diagnose at an early stage and has progressed to an advanced stage at the time of diagnosis, the treatment difficulty of patients is further increased.

[0003] Traditional treatment methods are often accompanied by serious side effects and damage to normal tissues. Therefore, finding more effective and precise treatment means is crucial for improving the survival rate of peritoneal cancer patients. In recent years, the development of nanotechnology has brought new opportunities to the field of cancer treatment. Nanomaterials have unique biological properties and can improve the treatment effect and reduce side effects by regulating drug release and enhancing drug targeting.

[0004] Artemisinin, a natural compound derived from Chinese herbal medicine, has gradually attracted attention in the research of anti-cancer fields. Artemisinin has anti-inflammatory, antioxidant, and anti-tumor properties, but it is restricted in practical applications due to problems such as poor solubility and low bioavailability. Therefore, combining artemisinin with nanotechnology and modifying nano-gold may bring a new breakthrough for the treatment of peritoneal cancer.

[0005] The present invention aims to overcome the limitations of existing treatment means and provide a drug complex based on artemisinin-modified nano-gold to improve the treatment effect of peritoneal cancer. By combining the anti-cancer properties of artemisinin and the biocompatibility of nano-gold, it is expected to achieve efficient targeted treatment of peritoneal cancer cells, relieve the pain of patients, and improve the survival rate. Summary of the Invention

[0006] The purpose of the present invention is: to solve the above technical problems, the present invention provides a method for preparing a nano-gold complex based on artemisinin for the treatment of peritoneal cancer.

[0007] The above technical purpose of the present invention is achieved through the following technical solutions: specifically including the following steps:

[0008] S1: Ensure that all glassware and tools used are strictly cleaned to avoid the introduction of impurities, and dissolve chloroauric acid salt (HAuCl4) in high-purity water to prepare a solution of gold ions. Usually, the concentration is in the range of 1 mM to 10 mM.

[0009] S2: Add reducing agents, usually sodium citrate and sodium borohydride (NaBH4), to reduce gold ions to gold nanoparticles. The specific steps are to slowly add a sodium borohydride (NaBH4) solution to the gold ion solution at room temperature of 20°C - 25°C, adjust the dropping rate to maintain a moderate reaction rate, and stir the solution to ensure uniform mixing.

[0010] S3: By adjusting the molar ratio of chloroaurate HAuCl4 and sodium borohydride NaBH4, control the size of the gold nanoparticles to be between 15 nm and 25 nm.

[0011] S4: During or after the synthesis of gold nanoparticles, introduce the surfactant polyvinylpyrrolidone (PVP) for modification, continuously stir the mixed solution to ensure that the surfactant fully coats the gold nanoparticles. The reaction time may range from 5 hours to 24 hours, depending on the required particle properties.

[0012] S5: Use a centrifuge to separate the gold nanoparticles from the reaction mixture, wash the particles with an appropriate solvent to remove unreacted reagents and impurities.

[0013] S6: Use techniques such as transmission electron microscopy (TEM) and scanning electron microscopy (SEM) to ensure that the shape, size, and surface properties of the gold nanoparticles meet the requirements of 15 nm - 25 nm.

[0014] S7: Artemisinin is modified to mercaptoartemisinin through a hydroxyl group. The reaction conditions are at room temperature and the reaction time is 24 hours. Use nuclear magnetic resonance (NMR) to confirm the structure of the functionalized artemisinin.

[0015] S8: React the functionalized artemisinin with the surface-modified gold nanoparticles, and observe the morphology of artemisinin-modified gold nanoparticles through transmission electron microscopy (TEM) to ensure that the gold nanoparticles are evenly dispersed and successfully modified.

[0016] S9: Remove unreacted substances by centrifugal filtration, then use dynamic light scattering (DLS) to measure the particle size distribution of the gold nanoparticles, and use Fourier transform infrared spectroscopy (FTIR) to characterize the artemisinin-modified gold nanoparticles to ensure that artemisinin is successfully modified onto the surface of the gold nanoparticles.

[0017] In summary, due to the adoption of the above technical solutions, the beneficial effects of the present invention are:

[0018] 1. Since the artemisinin-modified gold nanoparticles have surface functionalization and can bind to specific receptors or biomarkers on the surface of peritoneal cancer cells, they exhibit excellent targeting. This helps to achieve precise localization and treatment of peritoneal cancer cells in vivo.

[0019] 2. Gold nanoparticles have good biocompatibility in vivo, which can reduce the toxicity and side effects on normal tissues. Artemisinin-modified gold nanoparticles can pass through the blood circulation in the body more safely, helping to reduce the adverse reactions caused by treatment.

[0020] 3. Artemisinin itself has anti-cancer properties, and its combination with gold nanoparticles may produce a synergistic effect. Artemisinin-modified gold nanoparticles can affect peritoneal cancer cells through multiple pathways, including inhibiting cell proliferation, inducing apoptosis, and inhibiting angiogenesis, etc., so as to achieve a more effective anti-cancer effect.

[0021] 4. Due to the small particle size and surface functionalization of artemisinin-modified gold nanoparticles, it is expected to improve the bioavailability of nano-drugs, prolong the circulation time of drugs in the body, and enhance the enrichment of drugs in tumor tissues, thereby improving the drug delivery efficiency.

[0022] 5. The multiple effects of artemisinin-modified gold nanoparticles may help to reduce the multi-drug resistance of peritoneal cancer cells to drugs. This may be achieved by altering intracellular signal transduction, increasing the accumulation of drugs in cells, or through other mechanisms. Detailed implementation manners

[0023] Next, the technical solutions in the embodiments of the present invention will be clearly and completely described in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without making creative efforts belong to the scope of protection of the present invention.

[0024] Example 1:

[0025] A method for preparing gold nanoparticle composites based on artemisinin for the treatment of peritoneal cancer, the method comprising the following steps:

[0026] S1: Ensure that all glassware and tools used are strictly cleaned to avoid the introduction of impurities. Dissolve chloroaurate (HAuCl4) in high-purity water to prepare a solution of gold ions. Usually, a concentration in the range of 1 mM to 10 mM is used.

[0027] S2: Add reducing agents, usually sodium citrate and sodium borohydride (NaBH4), to reduce gold ions to gold nanoparticles. The specific steps are to slowly drop the sodium borohydride (NaBH4) solution into the gold ion solution at room temperature of 20 °C - 25 °C, adjust the dropping rate to maintain a moderate reaction rate, and stir the solution to ensure uniform mixing.

[0028] S3: By adjusting the molar ratio of chloroaurate HAuCl4 and sodium borohydride NaBH4, the size of gold nanoparticles is controlled to be between 15 nm and 25 nm.

[0029] S4: During or after the synthesis of gold nanoparticles, the surfactant polyvinylpyrrolidone (PVP) is introduced for modification. The mixed solution is continuously stirred to ensure that the surfactant fully wraps the gold nanoparticles. The reaction time may range from 5 hours to 24 hours, depending on the desired particle properties.

[0030] S5: The gold nanoparticles are separated from the reaction mixture by centrifugation using a centrifuge, and the particles are washed with an appropriate solvent to remove unreacted reagents and impurities.

[0031] S6: Using techniques such as transmission electron microscopy (TEM) and scanning electron microscopy (SEM), ensure that the shape, size, and surface properties of the gold nanoparticles meet the requirements of 15 nm - 25 nm.

[0032] S7: Artemisinin is modified to mercaptoartemisinin through hydroxylation. The reaction conditions are at room temperature and the reaction time is 24 hours. Nuclear magnetic resonance (NMR) is used to confirm the structure of the functionalized artemisinin.

[0033] S8: The functionalized artemisinin is reacted with the surface - modified gold nanoparticles. The morphology of artemisinin - modified gold nanoparticles is observed by transmission electron microscopy (TEM) to ensure that the gold nanoparticles are evenly dispersed and successfully modified.

[0034] S9: Unreacted substances are removed by centrifugal filtration, and then the particle size distribution of the gold nanoparticles is measured using dynamic light scattering (DLS). Fourier transform infrared spectroscopy (FTIR) is used to characterize the artemisinin - modified gold nanoparticles to ensure that artemisinin is successfully modified onto the surface of the gold nanoparticles.

[0035] The above description of the disclosed embodiments enables those skilled in the art to implement or use the present invention. Various modifications to these embodiments will be obvious to those skilled in the art, and the general principles defined herein can be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to these embodiments shown herein, but rather will be accorded the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A method for preparing a nano-gold complex based on artemisinin for treating peritoneal cancer, characterized in that, The method for preparing a nano-gold complex using artemisinin for treating peritoneal cancer comprises the following steps: S1: Ensure that all glassware and tools used are rigorously cleaned to avoid the introduction of impurities. Dissolve chloroaurate (HAuCl4) in high-purity water to prepare a solution of gold ions. Usually, a concentration in the range of 1 mM to 10 mM is used. S2: Add a reducing agent, usually sodium citrate and sodium borohydride (NaBH4), to reduce the gold ions to gold nanoparticles. The specific steps are to slowly add the sodium borohydride (NaBH4) solution to the gold ion solution at room temperature of 20°C - 25°C, adjust the dropping rate to maintain a moderate reaction rate, and stir the solution to ensure uniform mixing. S3: Control the size of the gold nanoparticles to be between 15 nm and 25 nm by adjusting the molar ratio of chloroaurate HAuCl4 and sodium borohydride NaBH4. S4: During or after the synthesis of the gold nanoparticles, introduce the surfactant polyvinylpyrrolidone (PVP) for modification. Continuously stir the mixed solution to ensure that the surfactant fully coats the gold nanoparticles. The reaction time may be in the range of 5 hours to 24 hours, depending on the desired particle characteristics. S5: Use a centrifuge to centrifuge and separate the gold nanoparticles from the reaction mixture, and wash the particles with an appropriate solvent to remove unreacted reagents and impurities. S6: Use techniques such as transmission electron microscopy (TEM) and scanning electron microscopy (SEM) to ensure that the shape, size, and surface properties of the gold nanoparticles meet the requirements of 15 nm - 25 nm. S7: Artemisinin is modified to mercapto-artemisinin through hydroxylation. The reaction conditions are at room temperature and the reaction time is 24 hours. Use nuclear magnetic resonance (NMR) to confirm the structure of the functionalized artemisinin. S8: React the functionalized artemisinin with the surface-modified gold nanoparticles. Observe the morphology of the artemisinin-modified gold nanoparticles through transmission electron microscopy (TEM) to ensure that the gold nanoparticles are uniformly dispersed and successfully modified. S9: Remove unreacted substances by centrifugal filtration, then use dynamic light scattering (DLS) to measure the particle size distribution of the gold nanoparticles, and use Fourier transform infrared spectroscopy (FTIR) to characterize the artemisinin-modified gold nanoparticles to ensure that artemisinin is successfully modified onto the surface of the gold nanoparticles.

2. A method for preparing a nano-gold complex based on artemisinin for treating peritoneal cancer according to claim 1, characterized in that, The temperature for using the reducing agent of the gold nanoparticles is 22°C.

3. A method for preparing a nano-gold complex based on artemisinin for treating peritoneal cancer according to claim 1, characterized in that, The size of the gold nanoparticles is 20 nm.

4. A method for preparing a nano-gold complex based on artemisinin for treating peritoneal cancer according to claim 1, wherein, For the introduction of the surfactant polyvinylpyrrolidone (PVP) for modification, continuously stir the mixed solution, and control the reaction time to be 12 hours.